Searched for
GERMAN COMPANY BIONTECH
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapyThe deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on expe...
- Germany’s BioNTech revises plans for African vaccine factory networkIn a potential blow for Africa’s hopes of greater vaccine self-reliance, the German biotech company is currently not moving forward with a ...
- Could cancer vaccines become a reality? Here’s what experts sayA cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- No need yet to adapt Pfizer vaccine for coronavirus variants, says BioNTech chiefA decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection again...
- Taiwan's Terry Gou, TSMC reach initial agreements for BioNTech vaccinesTaiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-rule...
- Taiwan says China blocked deal with BioNTech for COVID-19 shotsTaiwan has millions of vaccine doses on order, from AstraZeneca Plc and Moderna Inc, but has received only slightly more than 700,000 to da...
- Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...
- EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022: EU sourceThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...
- BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 billion dosesPfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021. BioNTech cited its new facility...
- BioNTech founders warn of vaccine supply gapsThe delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within d...
- EU reviews BioNTech request for 'extra dose' of virus shotIn an email to The Associated Press, the European Medicines Agency said that BioNTech, which developed its vaccine together with Pfizer, ha...
- China's Fosun plans plant to make BioNTech's COVID-19 vaccine: CaixinThe first phase of the China-based manufacturing facility will have production capacity of 200 million doses, Caixin said, citing people fa...
- BioNTech, Pfizer ask Europe to quickly approve virus vaccineThe German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional a...
- U.S. to pay Pfizer and BioNTech $1.95 billion to produce millions of doses of COVID-19 vaccinePfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...
- BioNTech and Pfizer's COVID-19 vaccine shows potential in human trialThe drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has...
- German company begins testing possible vaccineBioNTech said in a statement that in a next step, it will begin increasing the dose of BNT162 in a trial involving about 200 participants a...
- Pfizer, BioNTech to co-develop potential coronavirus vaccineThe drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...
Load More
